Skip to content

Acoustic Stimulation for Seizure Suppression

Low Frequency Acoustic Stimulation During Sleep for Seizure Suppression

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03198494
Enrollment
36
Registered
2017-06-26
Start date
2017-08-17
Completion date
2028-11-21
Last updated
2026-02-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Brief summary

The objective of this study is to test the feasibility and physiological effect of low-frequency (1 Hz) acoustic stimulation delivered during nocturnal NREM sleep in epilepsy patients. The long-term goal is to develop this protocol for daily, long-term use in a home setting, for nocturnal seizure and IED suppression

Detailed description

1. To test the feasibility of wearing an earphone system delivering acoustic stimulation during a night of sleep in adult epilepsy patients monitored in an inpatient unit. 2. To determine the acute physiological effects of low-frequency acoustic stimulation on interictal epileptiform discharge (IED) frequency during NREM sleep in adult patients with epilepsy in an ambulatory setting. 3. To determine the feasibility of applying low-frequency acoustic stimulation in a long-term home setting in adult epilepsy patients with frequent nocturnal seizures.

Interventions

OTHERAcoustic 1Hz Stimulation

1Hz acoustic pulses delivered during sleep via headphones

OTHERSham Background Noise

Background Noise used as a control

Sponsors

NYU Langone Health
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* 18-60 years old * Able to provide informed consent * MOCA ≥26 * Fluent in English * Frequent nocturnal IEDs (≥ 10% of the sleep record) * Monitored on the adult epilepsy monitoring unit (EMU, for Aim 1 only) Additional inclusion criteria for Aim 3 * Frequent nocturnal seizures (≥1 per week)

Exclusion criteria

* Hearing impairment * Diagnosis of a sleep disorder (sleep apnea, periodic limb movements of sleep, or other medical conditions with frequent arousals) * Psychoactive medication use (other than AEDs, for example SSRIs, antipsychotics, BDZ, or stimulants) * Seizures ≤ 24 hours prior to study. * Alcohol or recreational drug use in the 24 hours prior to the study * BMI ≥ 30 * MOCA \<26 * History of recent travel across time zones within the 1 month prior to study activities * Shift work for 1 month prior to study activities Additional

Design outcomes

Primary

MeasureTime frameDescription
Successful System Training72 hoursAssessment of how well participants learn to use stimulation smart-phone application and headphones, defined as the percentage of subjects with correctly maintained earphones during the first four hours of nocturnal sleep in the first days of use.
Interictal Discharge frequency72 hoursIED frequency during nighttime sleep as measured by a 72 hour ambulatory EEG
System Adherence2 monthsPercentage of nights during which patients were compliant with the acoustic stimulation device during two months of home use (1 month control acoustic condition, 1 month 1Hz stimulation) determined weekly by patient self-report

Secondary

MeasureTime frameDescription
System Use effect on Features of Sleep72 hoursEffect of system use on sleep features, including time spent in each stage of sleep, delta and spindle power and spatial distribution gather from EEG.
Seizure Control3 monthsSeizure frequency during control and treatment months gathered from seizure diary and IED frequency gathered from EEG (1 month baseline, 1 month sham stimulation, 1 month 1Hz stimulation).

Countries

United States

Contacts

PRINCIPAL_INVESTIGATORAnli Liu

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 28, 2026